<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US6001858 - Parasiticide formulations suitable for dermal application - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Parasiticide formulations suitable for dermal application"><meta name="DC.contributor" content="Kirkor Sirinyan" scheme="inventor"><meta name="DC.contributor" content="Hubert Dorn" scheme="inventor"><meta name="DC.contributor" content="Richard Kujanek" scheme="inventor"><meta name="DC.contributor" content="Klemens Krieger" scheme="inventor"><meta name="DC.contributor" content="Ulrich Heukamp" scheme="inventor"><meta name="DC.contributor" content="Doris Hackemuller" scheme="inventor"><meta name="DC.contributor" content="Terence Hopkins" scheme="inventor"><meta name="DC.contributor" content="Bayer Aktiengesellschaft" scheme="assignee"><meta name="DC.date" content="1995-11-27" scheme="dateSubmitted"><meta name="DC.description" content="The present invention relates to formulations for the dermal control of parasitic insects on animals, having the following composition agonists or antagonists of the nicotinergic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation; solvents from the group benzyl alcohol or optionally substituted pyrrolidones in a concentration of at least 20% by weight based on the overall weight of the formulation; if desired, further solvents from the group consisting of cyclic carbonates or lactones in a concentration of from 5.0 up to 80% by weight based on the overall weight of the formulation; if desired, further auxiliaries from the group thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, emulsifiers, in a concentration of from 0.025 up to 10% by weight based on the overall weight of the formulation."><meta name="DC.date" content="1999-12-14" scheme="issued"><meta name="DC.relation" content="EP:0303490:A1" scheme="references"><meta name="DC.relation" content="EP:0433909:A2" scheme="references"><meta name="DC.relation" content="EP:0483052:A1" scheme="references"><meta name="DC.relation" content="EP:0590425:A1" scheme="references"><meta name="DC.relation" content="GB:2194147" scheme="references"><meta name="DC.relation" content="GB:2236250" scheme="references"><meta name="DC.relation" content="GB:802111" scheme="references"><meta name="DC.relation" content="US:4415563" scheme="references"><meta name="DC.relation" content="US:4960771" scheme="references"><meta name="DC.relation" content="US:5194264" scheme="references"><meta name="DC.relation" content="US:5474783" scheme="references"><meta name="DC.relation" content="US:5482965" scheme="references"><meta name="DC.relation" content="US:5504081" scheme="references"><meta name="DC.relation" content="US:5656286" scheme="references"><meta name="DC.relation" content="WO:1993024002:A1" scheme="references"><meta name="citation_patent_number" content="US:6001858"><meta name="citation_patent_application_number" content="US:08/849,259"><link rel="canonical" href="http://www.google.com/patents/US6001858"/><meta property="og:url" content="http://www.google.com/patents/US6001858"/><meta name="title" content="Patent US6001858 - Parasiticide formulations suitable for dermal application"/><meta name="description" content="The present invention relates to formulations for the dermal control of parasitic insects on animals, having the following composition agonists or antagonists of the nicotinergic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation; solvents from the group benzyl alcohol or optionally substituted pyrrolidones in a concentration of at least 20% by weight based on the overall weight of the formulation; if desired, further solvents from the group consisting of cyclic carbonates or lactones in a concentration of from 5.0 up to 80% by weight based on the overall weight of the formulation; if desired, further auxiliaries from the group thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, emulsifiers, in a concentration of from 0.025 up to 10% by weight based on the overall weight of the formulation."/><meta property="og:title" content="Patent US6001858 - Parasiticide formulations suitable for dermal application"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("-EjsU9HgKIayggT7noCwAg"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("BRA"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("-EjsU9HgKIayggT7noCwAg"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("BRA"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us6001858?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US6001858"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=R6lNBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS6001858&amp;usg=AFQjCNHsYMsCI98pLsYXhVLa9bVMfIt7zA" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US6001858.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US6001858.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US6001858" style="display:none"><span itemprop="description">The present invention relates to formulations for the dermal control of parasitic insects on animals, having the following composition agonists or antagonists of the nicotinergic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation;...</span><span itemprop="url">http://www.google.com/patents/US6001858?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US6001858 - Parasiticide formulations suitable for dermal application</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US6001858 - Parasiticide formulations suitable for dermal application" title="Patent US6001858 - Parasiticide formulations suitable for dermal application"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US6001858 A</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 08/849,259</td></tr><tr><td class="patent-bibdata-heading">PCT number</td><td class="single-patent-bibdata">PCT/EP1995/004667</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Dec 14, 1999</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Nov 27, 1995</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Dec 9, 1994</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2207212A1">CA2207212A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2207212C">CA2207212C</a>, </span><span class="patent-bibdata-value"><a href="/patents/CN1089553C">CN1089553C</a>, </span><span class="patent-bibdata-value"><a href="/patents/CN1175188A">CN1175188A</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE4443888A1">DE4443888A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0796042A1">EP0796042A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0796042B1">EP0796042B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6372765">US6372765</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20020155140">US20020155140</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20060281792">US20060281792</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO1996017520A1">WO1996017520A1</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">08849259, </span><span class="patent-bibdata-value">849259, </span><span class="patent-bibdata-value">PCT/1995/4667, </span><span class="patent-bibdata-value">PCT/EP/1995/004667, </span><span class="patent-bibdata-value">PCT/EP/1995/04667, </span><span class="patent-bibdata-value">PCT/EP/95/004667, </span><span class="patent-bibdata-value">PCT/EP/95/04667, </span><span class="patent-bibdata-value">PCT/EP1995/004667, </span><span class="patent-bibdata-value">PCT/EP1995/04667, </span><span class="patent-bibdata-value">PCT/EP1995004667, </span><span class="patent-bibdata-value">PCT/EP199504667, </span><span class="patent-bibdata-value">PCT/EP95/004667, </span><span class="patent-bibdata-value">PCT/EP95/04667, </span><span class="patent-bibdata-value">PCT/EP95004667, </span><span class="patent-bibdata-value">PCT/EP9504667, </span><span class="patent-bibdata-value">US 6001858 A, </span><span class="patent-bibdata-value">US 6001858A, </span><span class="patent-bibdata-value">US-A-6001858, </span><span class="patent-bibdata-value">US6001858 A, </span><span class="patent-bibdata-value">US6001858A</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Kirkor+Sirinyan%22">Kirkor Sirinyan</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Hubert+Dorn%22">Hubert Dorn</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Richard+Kujanek%22">Richard Kujanek</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Klemens+Krieger%22">Klemens Krieger</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Ulrich+Heukamp%22">Ulrich Heukamp</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Doris+Hackemuller%22">Doris Hackemuller</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Terence+Hopkins%22">Terence Hopkins</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Bayer+Aktiengesellschaft%22">Bayer Aktiengesellschaft</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US6001858.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6001858.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6001858.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (15),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (15),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (13),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (9)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=R6lNBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/6001858&usg=AFQjCNF-JGFlxcjInOeJZXNT__M9Jtyyqw">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=R6lNBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D6001858&usg=AFQjCNEVVEScSvYG2q7EtAi7TwmxoK4BXg">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=R6lNBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D6001858A%26KC%3DA%26FT%3DD&usg=AFQjCNEjcUkFVo9vzheRM1SsUUe2OUmjlg">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT54537466" lang="EN" load-source="patent-office">Parasiticide formulations suitable for dermal application</invention-title></span><br><span class="patent-number">US 6001858 A</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA38008342" lang="EN" load-source="patent-office"> <div class="abstract">The present invention relates to formulations for the dermal control of parasitic insects on animals, having the following composition</div>
    <div class="abstract">agonists or antagonists of the nicotinergic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation;</div>
    <div class="abstract">solvents from the group benzyl alcohol or optionally substituted pyrrolidones in a concentration of at least 20% by weight based on the overall weight of the formulation;</div>
    <div class="abstract">if desired, further solvents from the group consisting of cyclic carbonates or lactones in a concentration of from 5.0 up to 80% by weight based on the overall weight of the formulation;</div>
    <div class="abstract">if desired, further auxiliaries from the group thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, emulsifiers, in a concentration of from 0.025 up to 10% by weight based on the overall weight of the formulation.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(11)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6001858-0.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6001858-0.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6001858-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6001858-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6001858-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6001858-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6001858-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6001858-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6001858-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6001858-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6001858-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6001858-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6001858-6.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6001858-6.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6001858-7.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6001858-7.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6001858-8.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6001858-8.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6001858-9.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6001858-9.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6001858-10.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6001858-10.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(3)</span></span></div><div class="patent-text"><div mxw-id="PCLM5495796" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>we claim:</claim-statement> <div class="claim"> <div num="1" class="claim">
      <div class="claim-text">1. A composition for the dermal control of parasitic insects on animals comprising: an agonist or antagonist of the nicotinergic acetylcholine receptors on insects in a concentration of from about 1% to about 20% by weight based on the overall weight of the composition comprising effective amount of the compound; ##STR13## a solvent selected from the group consisting of benzyl alcohols and optionally substituted pyrrolidones in a concentration of at least 20% to 90% by weight based on the overall weight of the composition, and optionally an additional solvent selected from the group consisting of cyclic carbonates and lactones in a concentration of from 5.0 up to 80% by weight based on the overall weight of the composition, and an auxiliary selected from the group consisting of thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, and emulsit.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" class="claim">
      <div class="claim-text">2. The composition according to claim 1 wherein the auxiliary is selected from the group consisting of thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives and emulsifiers in a concentration of from about 0.025% to about 10% by weight based on the overall weight of the composition.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" class="claim">
      <div class="claim-text">3. A method for the dermal control of parasitic insects on animals, comprising applying to an animal in need thereof a physiologically active amount of the composition according to claim 1.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES67387758" lang="EN" load-source="patent-office" class="description">
    <p>This application is a 371 of PCT/EP95/04667 filed Nov. 27, 1995.</p>
    <p>The present invention relates to formulations for the dermal control of parasitic insects on animals by means of agonists or antagonists of the nicotinergic acetylcholine receptors of insects.</p>
    <p>Agonists or antagonists of the nicotinergic acetylcholine receptors of insects are known. They include the nicotinyl insecticides and, very particularly, the chloronicotinyl insecticides.</p>
    <p>PCT application WO 93/24 002 discloses that certain 1-[N-(halo-3-pyridylmethyl)]-N-methylanino-1-alkylamino-2-nitroethylene derivatives are suitable for systemic use against fleas in domestic animals. According to WO 93/24 002, the nonsysternic--i.e. dermal--mode of application is unsuitable for the control of fleas on domestic animals.</p>
    <p>New formulations for the dermal application of agonists or antagonists of the nicotinergic acetylcholine receptors of insects have now been found which are particularly suitable for dermal control of parasitic insects, such as fleas, lice or flies, on animals.</p>
    <p>The formulations according to the invention have the following composition:</p>
    <p>agonists or antagonists of the nicotinergic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation;</p>
    <p>solvents from the group benzyl alcohol or optionally substituted pyrrolidones in a concentration of at least 20% by weight based on the overall weight of the formulation;</p>
    <p>if desired, further solvents from the group consisting of cyclic carbonates or lactones in a concentration of from 5.0 up to 80% by weight based on the overall weight of the formulation;</p>
    <p>if desired, further auxiliaries from the group thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, emulsifiers, in a concentration of from 0.025 up to 10% by weight based on the overall weight of the formulation.</p>
    <p>Agonists or antagonists of the nicotinergic acetylcholine receptors of insects are known, for example, from European Offenlegungsschriften (European Published Applications) Nos. 464 830, 428 941, 425 978, 386 565, 383 091, 375 907, 364 844, 315 826, 259 738, 254 859, 235 725, 212 600, 192 060, 163 855, 154 178, 136 636, 303 570, 302 833, 306 696, 189 972, 455 000, 135 956, 471 372, 302 389; German Offenlegungsschriften (Gerrnan Published Specifications) Nos. 3 639 877, 3 712 307; Japanese Offenlegungsschriften (Japanese Published Applications) Nos. 03 220 176, 02 207 083, 63 307 857, 63 287 764, 03 246 283, 04 9371, 03 279 359, 03 255 072, U.S. Pat. Nos. 5,034,524, 4,948,798, 4,918,086, 5,039,686, 5,034,404; PCT Applications Nos. WO 91/17 659, 91/4965; French Application No. 2 611 114; Brazilian Application No. 88 03 621.</p>
    <p>Express reference is hereby made to the compounds described in these publications and to their preparation.</p>
    <p>These compounds can be represented preferably by the general formula (I) ##STR1## in which R represents, hydrogen, optionally substituted radicals from the group acyl, alkyl, aryl, aralkyl, heteroaryl or heteroarylalkyl;</p>
    <p>A represents a monofinctional group from the series hydrogen, acyl, alkyl, aryl, or represents a bifinctional group which is linked to the radical Z;</p>
    <p>E represents an electron-withdrawing radical;</p>
    <p>X represents the radicals --CH═ or ═N--, it being possible for the radical --CH═ instead of a H-atom to be linked to the radical Z;</p>
    <p>Z represents a monofwnctional group from the series alkyl, --O--R, --S--R, ##STR2## or represents a bifunctional group which is linked to the radical A or to the radical X.</p>
    <p>Particularly preferred compounds of the formula (I) are those in which the radicals have the following meaning:</p>
    <p>R represents hydrogen and represents optionally substituted radicals from the series acyl, alkyl, aryl, aralkyl, heteroaryl, heteroarylalkyl.</p>
    <p>Acyl radicals which may be mentioned are formyl, alkylcarbonyl, arylcarbonyl, alkylsulphony, arylsulphonyl, (alkyl)-(aryl)-phosphoryl, which may in turn be substituted.</p>
    <p>As alkyl there may be mentioned C<sub>1-10</sub> -alkyl, especially C<sub>1-4</sub> -alkyl, specifically methyl, ethyl, i-propyl, sec- or t-butyl, which may in turn be substituted.</p>
    <p>As aryl there may be mentioned phenyl, naphthyl, especially phenyl.</p>
    <p>As mlkyl there may be mentioned phenylmethyl, phenethyl.</p>
    <p>As heteroaryl there may be mentioned heteroaryl having up to 10 ring atoms and N, O, S especially N as heteroatoms. Specifically there may be mentioned thienyl, furyl, thiazolyl, imidazolyl, pyridyl, benzothiazolyl,</p>
    <p>As heteroarylallyl there may be mentioned heteroarylrnethyl, heteroarylethyl having up to 6 ring atoms and N, O, S, especially N as heteroatoms.</p>
    <p>Substituents which may be listed by way of example and preference are: alkyl having preferably 1 to 4, in particular 1 or 2 carbon atoms, such as methyl, ethyl, n- and i-propyl and n-, i- and t-butyl; alkoxy having preferably 1 to 4, in particular 1 or 2 carbon atoms, such as methoxy, ethoxy, n- and i-propyloxy and n-, i- and t-butyloxy; alkylthio having preferably 1 to 4, in particular 1 or 2 carbon atoms, such as methylthio, ethylthio, n- and i-propylthio and n-, i- and t-butylthio; halogenoalkyl having preferably 1 to 4, in particular 1 or 2 carbon atoms and preferably 1 to 5, in particular 1 to 3 halogen atoms, the halogen atoms being identical or different and being preferably fluorine, chlorine or bromine, especially fluorine, such as trifluoromethyl; hydroxyl; halogen, preferably fluorine, chlorine, bromine and iodine, especially fluorine, chlorine and bromine; cyano; nitro; amino; monoalkyl- and dialkylamino having preferably 1 to 4, in particular 1 or 2 carbon atoms per alkyl group, such as methylamino, methyl-ethyl-amino, n- and i-propylanino and methyl-n-butylamino; carboxyl; carbalkoxy having preferably 2 to 4, in particular 2 or 3 carbon atoms, such as carbomethoxy and carboethoxy; sulpho (--SO<sub>3</sub> H); atkylsulphonyl having preferably 1 to 4, in particular 1 or 2 carbon atoms, such as methylsulphonyl and ethylsulphonyl; arylsulphonyl having preferably 6 or 10 aryl carbon atonms, such as phenylsulphonyl, and also heteroarylamino and heteroarylalkylamino such as chloropyridylamino and chloropyridylmethylamino.</p>
    <p>A particularly preferably represents hydrogen and represents optionally substituted radicals from the series acyl, alkyl, aryl, which preferably have the meanings given for R. A additionally represents a bifunctional group. There may be mentioned optionally substituted alkylene having 1-4, in particular 1-2 C atoms, substituents which may be mentioned being the substituents listed earlier above, and it being possible for the alkylene groups to be interrupted by heteroatomns from the series N, O, S.</p>
    <p>A and Z may, together with the atoms to which they are attached, form a saturated or unsaturated heterocyclic ring. The heterocyclic ring can contain a further 1 or 2 identical or different heteroatoms and/or hetero-groups. Heteroatoms are preferably oxygen, sulphur or nitrogen, and hetero-groups are preferably N-alkyl, where the alkyl in the N-alkyl group preferably contains 1 to 4, in particular 1 or 2 carbon atoms. As alkyl there may be mentioned methyl, ethyl, n- and i-propyl and n-, i- and t-butyl. The heterocyclic ring contains 5 to 7, preferably 5 or 6 ring members.</p>
    <p>Examples of the heterocyclic ring which may be mentioned are pyrrolidine, piperidine, piperazine, hexamethyleneirnine, hexahydro-1,3,5-triazine, morpholine, each of which may optionally be substituted preferably by methyl.</p>
    <p>E represents an electron-withdrawing radical, in which context particular mention may be made of NO<sub>2</sub>, CN, halogenoalkylcarbonyl such as 1,5-halogeno-C<sub>1-4</sub> -carbonyl especially COCF<sub>3</sub>.</p>
    <p>X represents --CH═ or --N═</p>
    <p>Z represents optionally substituted radicals, alkyl, --OR, --SR, --NRR, where R and the substituents preferably have the meaning given above.</p>
    <p>Z can form, apart from the abovementioned ring, and together with the atom to which it is attached and with the radical ##STR3## instead of X a saturated or unsaturated heterocyclic ring. The heterocyclic ring can contain a further 1 or 2 identical or different heteroatoms and/or hetero-groups. The heteroatoms are preferably oxygen, sulphur or nitrogen, and the hetero-groups N-alkyl, in which case the alkyl or N-alkyl group preferably contains 1 to 4, in particular 1 or 2 carbon atoms. As alkyl there may be mentioned methyl, ethyl, n- and i-propyl and n-, i- and t-butyl. The heterocyclic ring contains 5 to 7, preferably 5 or 6 ring members.</p>
    <p>Examples of the heterocyclic ring which may be mentioned are pyrrolidine, piperidine, piperazine, hexamethyleneimine, morpholine and N-methylpiperazine.</p>
    <p>As compounds which may be used with very particular preference in accordance with the invention, mention may be made of compounds of the general formulae (II) and (III): ##STR4## in which n represents 1 or 2,</p>
    <p>subst. represents one of the above-listed substituents, especially halogen, very particularly chlorine,</p>
    <p>A, Z, X and E have the meanings given above,</p>
    <p>Specifically, the following compounds may be mentioned: ##STR5##</p>
    <p>The formulations according to the invention contain the active substance in concentrations of from 0.1 to 20% by weight, preferably from 1 to 12.5% by weight.</p>
    <p>Preparations which are diluted before use contain the active substance in concentrations of from 0.5 to 90% by weight, preferably from 1 to 50% by weight.</p>
    <p>In general it has proved to be advantageous to administer quantities of from about 0.5 to about 50 mg, preferably from 1 to 20 mg, of active substance per body weight per day in order to achieve effective results.</p>
    <p>Suitable solvents are:</p>
    <p>benzyl alcohol or optionally substituted pyrrolidones such as 2-pyrrolidone, 1-(C<sub>2-20</sub> -alkyl)-2-pyrrolidone, in particular 1-ethylpyrrolidone, 1-octylpyrrolidone, 1-dodecylpyrrolidone, 1-isopropylpyrrolidone, 1-(s- or t- or n-butyl)pyrrolidone, 1-hexylpyrrolidone, 1-(C<sub>2-20</sub> -alkenyl)-2-pyrrolidone such as 1-vinyl-2-pyrrolidone, 1-(C<sub>3-8</sub> -cycloalkyl)-2-pyrrolidone such as 1-cyclohexylpyrrolidone, 1-(C<sub>1-6</sub> -hydroxyalkyl)-2-pyrrolidone, 1-(C<sub>1-6</sub> -alkoxy-C<sub>1-6</sub> -alkyl)-2-pyrrolidone such as 1-(2-hydroxyethyl)-pyrrolidone, 1-(3-hydroxypropyl)pyrrolidone, 1-(2-methoxyethyl)-pyrrolidone, 1-(3-methoxypropyl)-pyrrolidone, and also 1-benzylpyrrolidone. Particular mention may be made of benzyl alcohol or n-dodecyl- or n-octylpyrrolidone. These solvents can be employed either alone or in a mixture with additional solvents (cosolvents).</p>
    <p>They are present in a concentration of at least 20% by weigh; preferably from 40 to 90% by weight, particularly preferably from 50 to 90% by weight.</p>
    <p>Suitable additional solvents or cosolvents are: cyclic carbonates or lactones. As such there may be mentioned: ethylene carbonate, propylene carbonate, γ-butyrolactone.</p>
    <p>They are present in a concentration from 5.0 up to 80% by weight, preferably from 7.5 to 50% by weight, particularly preferably from 10 to 50% by weight.</p>
    <p>Suitable further auxiliaries are: preservatives such as benzyl alcohol (not required if already present as solvent), trichlorobutanol, p-hydroxybenzoic esters, n-butanol.</p>
    <p>Thickeners such as: inorganic thickeners such as bentonites, colloidal silicic acid, aluninium monostearate, organic thickeners such as cellulose derivatives, polyvinyl alcohols, polyvinylpyrrolidones and copolymers thereof, acrylates and methacrylates.</p>
    <p>Colorants which may be mentioned are all colorants where use on the animal is permitted, which may be dissolved or suspended.</p>
    <p>Auxiliaries are also spreading oils such as di-2-ethylhexyl adipate, isopropyl myristate, dipropylene glycol pelargonate, cyclic and acyclic silicone oils such as dimeticones and also co- and terpolymers thereof with ethylene oxide, propylene oxide and formalin, fatty acid esters, triglycerides, fatty alcohols.</p>
    <p>Antioxidants are sulphites or metabisuiphites such as potassium metabisuiphite, a scorbic acid, butylated hydroxytoluene, butylated hydroxyanisole, tocopherol.</p>
    <p>Light stabilizers are, for example, substances from the class of the benzophenones or Novantisol acid.</p>
    <p>Adhesives are, for example, cellulose derivatives, starch derivatives, polyacrylates, naturally occurring polymers such as alginates, gelatin.</p>
    <p>Auxiliaries are also emulsifiers such as nonionic surfactants, for example polyoxyethylated castor oil, polyoxyethiylated sorbitan monooleate, sorbitan monostearate, glycerol monostearate, polyoxyethylstearate, alkylphenol polyglycol ethers;</p>
    <p>ampholytic surfactants such as di-Na N-lauryl-β-ininodipropionate or lecithin;</p>
    <p>anionic surfactants, such as Na-lauryl sulphate, fatty alcohol ether sulphates, mono/dialkyl-polyglycol ether orthophosphoric ester monoethanolamine salt; cationic surfactants such as cetyltrimethylammonium chloride.</p>
    <p>Further auxiliaries are agents with which the formulations according to the invention can be sprayed or squirted onto the skin. These are the conventional propellent gases required for spray cans, such as propane, butane, dimethyl ether, CO<sub>2</sub> or halogenated lower alkanes, or mixtures thereof with one another.</p>
    <p>While being of low toxicity to warm-blooded species, the formulations according to the invention are suitable for the control of parasitic insects which are encountered in animal keeping and animal breeding in domestic and productive animals and in zoo and laboratory animals and animals used for experimentation and in the pursuit of hobbies. In this context they are active against all or individual stages of development of the pests and against resistant and normally sensitive species of the pests.</p>
    <p>The pests include:</p>
    <p>from the order of the Anoplura e.g. Haematopinus spp., Linognathus spp., Solenopotes spp., Pediculus spp., Pthirus spp.; from the order of the Mallophaga e.g. Trimenopon spp., Menopon spp., Eomenacanthus spp., Menacanthus spp., Trichodectes spp., Felicola spp., Damalinea spp., Bovicola spp; from the order of the Diptera e.g. Chrysops spp., Tabanus spp., Musca spp., Hydrotaea spp., Muscina spp., Haematobosca spp., Haematobia spp., Stomoxys spp., Fannia spp., Glossina spp., Lucilia spp., Calliphora spp., Auchmeromyia spp., Cordylobia spp., Cochliomyia spp., Chrysomyia spp., Sarcophaga spp., Wohlfartia spp., Gasterophilus spp., Oesteromyia spp., Oedemagena spp., Hypoderma spp., Oestuus spp., Rhinoestrus spp., Melophagus spp., Hippobosca spp.</p>
    <p>From the order of the Siphonaptera e.g. Ctenocephalides spp., Echidnophaga spp., Ceratophyllus spp.</p>
    <p>Particular mention may be made of the action against Siphonaptera, especially against fleas.</p>
    <p>The productive and breeding animals include mammals such as, for example, cattle, horses, sheep, pigs, goats, camels, water buffalo, donkeys, rabbits, fallow deer, reindeer, fur-bearing animals such as, for example, mink, chinchilla or racoon, birds such as, for example, chickens, geese, turkeys, ducks.</p>
    <p>Laboratory animals and those for experimentation include mice, rats, guinea pigs, golden hamsters, dogs and cats.</p>
    <p>The hobby animals include dogs and cats.</p>
    <p>Administration can be effected both prophylactically and therapeutically.</p>
    <p>In the shaped articles according to the invention, it is also possible for further active substances to be present. The further active substances include insecticides such as phosphorus-containing compounds, i.e. phosphates or phosphonates, natural or synthetic pyrethroides, carbamates, amidines, juvenile hormones and juvenoid synthetic active substances, and chitin synthesis inhbitors such as diaryl ethers and benzoylureas.</p>
    <p>The phosphates or phosphonates include:</p>
    <p>0-ethyl-0-(8-quinopyl)phenyl thiophosphate (quintiofos),</p>
    <p>0,0-diethyl 0-(3-chloro-4-methyl-7-coumarinyl)-thiophosphate (coumaphos),</p>
    <p>0,0-diethyl 0-phenylglycoxylonitrice oxime thiophosphate (phoxim),</p>
    <p>0,0-diethyl 0-cyanochlorobedoxine thiophosphate (chlorphoxim),</p>
    <p>0,0-diethyl 0-(4-bromo2,5-dichlorophenyl) phosphorothionate (bromophos-ethyl),</p>
    <p>0,0,0',0'-tetraethyl S,S'-methylene-di(phosphorodithionate) (ethion),</p>
    <p>2,3-p-dioxanedithiol S,S-bis(0,0-diethyl phosphorodithionate),</p>
    <p>2-chloro-1-(2,4-dichlorophenyl)-vinyl diethyl phosphate (chlorfenvinphos),</p>
    <p>0,0-dimethyl 0-(3-methyl-4-methylthiophenyl) thionophosphate (fenthion).</p>
    <p>The carbamates include:</p>
    <p>2-isopropoxyphenyl methylcarbamate (propoxur),</p>
    <p>1-naphthyl N-methylcarbamate (carbaryl).</p>
    <p>The synthetic pyrethroides include</p>
    <p>3-[2-(4-chlorophenyl)-2-chlorovinyl]-2,2-dimethyl-cyclo-propanecarboxylic acid (∝-cyano-4-fluoro-3-phenoxy)-benzyl ester (flumethrin),</p>
    <p>∝-cyano(4-fluoro-3-phenoxy)-benzyl 2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropanecarboxylate (cyfluthrin) and its enantiomers and stereomers,</p>
    <p>∝-cyano-3-phenoxybenzyl (±)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (deltamethrin),</p>
    <p>∝-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropanecarboxylate (cypermethrin),</p>
    <p>3-phenoxybenzyl (±)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (permethrin),</p>
    <p>∝-cyano-3-phenoxy-benzyl ∝-(p-Cl-phenyl)-isovalerate (fenvalerate),</p>
    <p>2-cyano-3-phenoxybenzyl 2-(2-chloro-∝,∝,∝-trifluoro-p-toluidino)-3-methylbutyrate (fluvalinate).</p>
    <p>The amidines include:</p>
    <p>3-methyl-2-[2,4-dimethyl-phenylimino]-thiazoline,</p>
    <p>2-(4-chloro-2-methylphenylimino)-3-methylthiazolidine,</p>
    <p>2-(4-chloro-2-methylphenylimino)-3-(isobutyl-1-enyl)-thiazolidine</p>
    <p>1,5-bis-(2,4-dimethylphenyl)-3-methyl-1,3,5-triazapenta-1,4-diene (amitraz).</p>
    <p>Cyclic macroliths such as invermectins and abamectins. In this context there may be mentioned, for example, 5-0-dimethyl-22,23-dihydroavermectin-A<sub>1a</sub>, -22,23-dihydroavermectin B<sub>1a</sub> and 22,23-dihydroavermectin B<sub>b1</sub> (cf. for example WHO.</p>
    <p>F.A Series 27, pp. 27-73 (1991)). The juvenile honnones and juvenile hormone-like substances include, in particular, compounds of the following formulae: ##STR6##</p>
    <p>The substituted dial ethers include, in particular</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________  #STR7##R<sup>1</sup>  R<sup>3</sup>  R<sup>5</sup>   R<sup>6</sup> Z______________________________________H        H        CH<sub>3</sub>  H       O  H H CH<sub>3</sub> 2-Cl O  5-F H CH<sub>3</sub> H O  H H CF<sub>3</sub> H O  H H C<sub>2</sub> H<sub>5</sub> H O  H H H H O  H H CH<sub>3</sub> H CH<sub>2</sub>  H H CH<sub>3</sub> H C(CH<sub>3</sub>)<sub>2</sub>______________________________________</pre>
    
    <p>The benzoyl uireas include compounds of the formula</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________  #STR8##R<sup>1</sup>     R<sup>2</sup>   R<sup>4</sup>______________________________________H           Cl        CF<sub>3</sub>  Cl Cl CF<sub>3</sub>  F F CF<sub>3</sub>  H F CF<sub>3</sub>  H Cl SCF<sub>3</sub>  F F SCF<sub>3</sub>  H F SCF<sub>3</sub>  H Cl OCF<sub>3</sub>  F F OCF<sub>3</sub>  H F OCF<sub>3</sub>   - F F                   #STR9##   - F F                   #STR10##   - F F                  ##STR11##______________________________________</pre>
    
    <p>The triazineinclus compounds of the formula</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________  #STR12##R<sub>1</sub>    R<sub>2</sub>        R<sub>3</sub>______________________________________Cyclopropyl      H              H  Cyclopropyl H CH<sub>3</sub>  Cyclopropyl H C<sub>2</sub> H<sub>5</sub>  Cyclopropyl H C<sub>3</sub> H<sub>7</sub> -n  Cyclopropyl H C<sub>4</sub> H<sub>9</sub> -n  Cyclopropyl H C<sub>5</sub> H<sub>11</sub> -n  Cyclopropyl H C<sub>6</sub> H<sub>13</sub> -n  Cyclopropyl H C<sub>7</sub> H<sub>15</sub> -n  Cyclopropyl H C<sub>8</sub> H<sub>17</sub> -n  Cyclopropyl H C<sub>12</sub> H<sub>25</sub> -n  Cyclopropyl H CH<sub>2</sub> --C<sub>4</sub> H<sub>9</sub> -n  Cyclopropyl H CH<sub>2</sub> CH(CH<sub>3</sub>)C<sub>2</sub> H<sub>5</sub>  Cyclopropyl H CH<sub>2</sub> CH═CH<sub>2</sub>  Cyclopropyl Cl C<sub>2</sub> H<sub>5</sub>  Cyclopropyl Cl C<sub>6</sub> H<sub>13-n</sub>  Cyclopropyl Cl C<sub>8</sub> H<sub>17-n</sub>  Cyclopropyl Cl C<sub>12</sub> H<sub>25</sub> -n  Cyclopropyl H Cyclopropyl  Cyclopropyl H COCH<sub>3</sub>  Cyclopropyl H COCH<sub>3</sub> HCl  Cyclopropyl H COC<sub>2</sub> H<sub>5</sub> HCl  Cyclopropyl H COC<sub>2</sub> H<sub>5</sub>  Cyclopropyl H COC<sub>3</sub> H<sub>7</sub> -n  Cyclopropyl H COC<sub>3</sub> H<sub>7</sub> -i  Cyclopropyl H COC<sub>4</sub> H<sub>9</sub> -t HCl  Cyclopropyl H COC<sub>4</sub> H<sub>9</sub> -n  Cyclopropyl H COC<sub>6</sub> H<sub>13</sub> -n  Cyclopropyl H COC<sub>11</sub> --H<sub>23</sub> -n  Cyclopropyl COCH<sub>3</sub> COC<sub>2</sub> H<sub>5</sub>  Cyclopropyl COC<sub>3</sub> H<sub>7</sub> -n COC<sub>6</sub> H<sub>13</sub> -n  Cyclopropyl COCH<sub>3</sub> COC<sub>3</sub> H<sub>7</sub> -n  Cyclopropyl COC<sub>2</sub> H<sub>5</sub> COC<sub>3</sub> H<sub>7</sub> -n  Cyclopropyl H COCyclopropyl  Cyclopropyl COCyclopropyl COCyclopropyl  Cyclopropyl COCH<sub>3</sub> COCH<sub>3</sub>  Isopropyl H H  Isopropyl H COCH<sub>3</sub>  Isopropyl H COC<sub>3</sub> H<sub>7</sub> -n  Cyclopropyl H CONHCH<sub>3</sub>  Cyclopropyl H CONHC<sub>3</sub> H<sub>7</sub> -i  Cyclopropyl CONHCH<sub>3</sub> CONHCH<sub>3</sub>  Cyclopropyl H SCNHCH<sub>3</sub>  Cyclopropyl H CONHCH<sub>2</sub> CH═CH<sub>2</sub>  Cyclopropyl CONHCH<sub>2</sub> CH═CH<sub>2</sub> CONHCH<sub>2</sub> CH═CH<sub>2</sub>                      Cyclopropyl CSNHCH<sub>3</sub> CSNHCH<sub>3</sub>______________________________________</pre>
    
    <p>Particular emphasis should be given to the further active substances having the common names propoxur, cyfluthrin, flumewfrin, pyriproxyfen, methoprene, diazinon, amitraz, fenthion and levamisol.</p>
    <p>In the examples which follow, the active substance employed is 1-[(6-chloro-3-pyridinyl)methyl]-N-nitro-2-imidazolidinium (common name imidacloprid).</p>
    <heading>EXAMPLE</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Imidacloprid           10    g  Propylene carbonate 45 g  Benzyl alcohol 45 g  ® Belsil DMC 6031 1 g______________________________________ (A polysiloxane copolymer from Wacker GmbH, D81737 Munich)</pre>
    
    <heading>EXAMPLE</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Imidacloprid           10     g  n-octyl-2-pyrrolidone 44.5 g  γ-butyrolactone 44.5 g  ® Belsil L 066 1 g______________________________________ (A polysiloxane copolymer from Wacker GmbH, D81737 Munich)</pre>
    
    <heading>EXAMPLE</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Imidacloprid           8.5    g  n-dodecyl-pyrrolidone 45.25 g  γ-butyrolactone 45.25 g  ® Belsil L 066 1 g______________________________________ (Polysiloxane copolymer as spreading agent)</pre>
    
    <heading>EXAMPLE</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Imidacloprid          10     g  Benzyl alcohol 89.9 g  ® Belsil DMC 6031 0.1 g______________________________________ (polysiloxane copolymer as spreading agent)</pre>
    
    <heading>EXAMPLE</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Imidacloprid          12.5   g  Benzyl alcohol 70.0 g  propylene carbonate 17.5 g______________________________________</pre>
    
    <heading>EXAMPLE</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Imidacloprid           10.0   g  1-cyclohexylpyrrolidone 80.0 g  Propylene carbonate 10.0 g______________________________________</pre>
    
    <heading>EXAMPLE</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Imidacloprid          11.0    g  Benzyl alcohol 70.0 g  Propylene carbonate 15.0 g  Isopropyl myristate 4.0 g______________________________________</pre>
    
    <heading>EXAMPLE</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Imidacloprid           12.5   g  Benzyl alcohol 70.0 g  Propylene carbonate 17.4 g  Butylated hydroxytoluene 0.1 g______________________________________</pre>
    
    <heading>EXAMPLE</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Imidacloprid           10.0   g  Benzyl alcohol 70.0 g  Propylene carbonate 17.5 g  Di-2-ethylhexyl adipate 2.5 g______________________________________</pre>
    
    <heading>EXAMPLE</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Imidacloprid          12.5   g  2-pyrrolidone 70.0 g  Propylene carbonate 17.5 g______________________________________</pre>
    
    <heading>EXAMPLE</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Imidacloprid           10.0   g  Pyriproxyfen 1.0 g  Benzyl alcohol 70.0 g  Propylene carbonate 18.9 g  Butylated hydroxytoluene 0.1 g______________________________________</pre>
    
    <heading>EXAMPLE</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Imidacloprid          12.5   g  Triflumuron 2.5 g  Benzyl alcohol 60.0 g  Propylene carbonate 27.5 g______________________________________</pre>
    
    <heading>EXAMPLE</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Imidacloprid          10.0   g  Flumetrin 2.0 g  Benzyl alcohol 60.0 g  Propylene carbonate 28.0 g______________________________________</pre>
    
    <heading>EXAMPLE</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Imidacloprid          10.0   g  Benzyl alcohol 60.0 g  Ethylene carbonate 15.0 g  Propylene carbonate 15.0 g______________________________________</pre>
    
    <heading>USE EXAMPLE A</heading> <p>2 ml of the formulation described in Example 1 was poured onto the back of a dog weighing 20 kg which was ineted with fleas. The following results were obtained:</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________           Number of fleas  Period of time per dogDay             Untreated Treated  % Action______________________________________-1 Infestation with 100 fleas  0 Treatment and counting 30 0 100  5, 8 Infestation with 100 fleas  9 Counting 56 0 100  15 Infestation with 100 fleas  16 Counting 76 0 100  19 Infestation with 100 fleas  (untreated animals)  250 fleas (treated animals)  20 Counting 39 0 100  26 Infestation with 100 fleas  27 Counting 43 0 100______________________________________</pre>
    
    <heading>USE EXAMPLE B</heading> <p>1 ml of the solution according to Example 4 was placed on the shoulders of a dog weighing 20 kg. The animal was infested with 200 fleas after 2 and after 6 days of treatment. On day 3 and on day 7, respectively, of the treatment, the fleas remaining on the dog were counted. No living fleas were found. The action was 100%.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4415563">US4415563</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 7, 1981</td><td class="patent-data-table-td patent-date-value">Nov 15, 1983</td><td class="patent-data-table-td ">Nelson Research &amp; Development Company</td><td class="patent-data-table-td ">Topical application of medicine; cosmetics</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4960771">US4960771</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 12, 1988</td><td class="patent-data-table-td patent-date-value">Oct 2, 1990</td><td class="patent-data-table-td ">Rajadhyaksha Vithal J</td><td class="patent-data-table-td ">Oxazolidinone penetration enhancing compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5194264">US5194264</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 13, 1990</td><td class="patent-data-table-td patent-date-value">Mar 16, 1993</td><td class="patent-data-table-td ">Scientific Chemicals (Proprietary) Limited</td><td class="patent-data-table-td ">Pesticidal formulation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5474783">US5474783</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 27, 1991</td><td class="patent-data-table-td patent-date-value">Dec 12, 1995</td><td class="patent-data-table-td ">Noven Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">In the form of sheet; used for applying to the dermis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5482965">US5482965</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 3, 1993</td><td class="patent-data-table-td patent-date-value">Jan 9, 1996</td><td class="patent-data-table-td ">Rajadhyaksha; Vithal J.</td><td class="patent-data-table-td ">Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers for physiological active agents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5504081">US5504081</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 22, 1993</td><td class="patent-data-table-td patent-date-value">Apr 2, 1996</td><td class="patent-data-table-td ">Bayer Aktiengesellschaft</td><td class="patent-data-table-td ">Administering nicotinergic acetylcholine receptor antagonists and agonists</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5656286">US5656286</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 7, 1994</td><td class="patent-data-table-td patent-date-value">Aug 12, 1997</td><td class="patent-data-table-td ">Noven Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Solubility parameter based drug delivery system and method for altering drug saturation concentration</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0303490A1?cl=en">EP0303490A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 11, 1988</td><td class="patent-data-table-td patent-date-value">Feb 15, 1989</td><td class="patent-data-table-td ">Purepac, Inc.</td><td class="patent-data-table-td ">Transdermal adminstration using benzyl alcohol</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0433909A2?cl=en">EP0433909A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 14, 1990</td><td class="patent-data-table-td patent-date-value">Jun 26, 1991</td><td class="patent-data-table-td ">Ciba-Geigy Ag</td><td class="patent-data-table-td ">Formulation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0483052A1?cl=en">EP0483052A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 11, 1991</td><td class="patent-data-table-td patent-date-value">Apr 29, 1992</td><td class="patent-data-table-td ">Ciba-Geigy Ag</td><td class="patent-data-table-td ">Picolinoxides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0590425A1?cl=en">EP0590425A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 16, 1993</td><td class="patent-data-table-td patent-date-value">Apr 6, 1994</td><td class="patent-data-table-td ">Bayer Ag</td><td class="patent-data-table-td ">Control of fish parasites</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=R6lNBAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DGB%26NR%3D802111A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNFUWpL8bZkvKWkrJ9PgaHnpKmDqTA">GB802111A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=R6lNBAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DGB%26NR%3D2194147A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNFrzek3qFXc36uwOGSwu8wAjspOkg">GB2194147A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=R6lNBAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DGB%26NR%3D2236250A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNHmsDMVtNHCd9FnLnz2HRK88uOssg">GB2236250A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1993024002A1?cl=en">WO1993024002A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 23, 1992</td><td class="patent-data-table-td patent-date-value">Dec 9, 1993</td><td class="patent-data-table-td ">Ciba Geigy Ag</td><td class="patent-data-table-td ">1-[n-(halo-3-pyridylmethyl)]-n-methylamino-1-alkylamino-2-nitroethylene derivatives for use against fleas on pets</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6369054">US6369054</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 10, 1999</td><td class="patent-data-table-td patent-date-value">Apr 9, 2002</td><td class="patent-data-table-td ">Bayer Ag</td><td class="patent-data-table-td ">Agonists or antagonists of the nicotinic acetylcholine receptors of insects; chloronicotinyl insecticides; cyclic carbonate, acyclic alcohol</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6372765">US6372765</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 5, 1999</td><td class="patent-data-table-td patent-date-value">Apr 16, 2002</td><td class="patent-data-table-td ">Bayer Aktiengesellschaft</td><td class="patent-data-table-td ">Skin parasites treated with solvent</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6617314">US6617314</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 8, 1997</td><td class="patent-data-table-td patent-date-value">Sep 9, 2003</td><td class="patent-data-table-td ">Bayer Aktiengesellschaft</td><td class="patent-data-table-td ">Injectable formulations of avermectins and milbemycins</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6663876">US6663876</a></td><td class="patent-data-table-td patent-date-value">Apr 29, 2002</td><td class="patent-data-table-td patent-date-value">Dec 16, 2003</td><td class="patent-data-table-td ">Piedmont Pharmaceuticals, Llc</td><td class="patent-data-table-td ">Methods and compositions for treating ectoparasite infestation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6867169">US6867169</a></td><td class="patent-data-table-td patent-date-value">Nov 20, 2000</td><td class="patent-data-table-td patent-date-value">Mar 15, 2005</td><td class="patent-data-table-td ">Syngenta Crop Protection, Inc.</td><td class="patent-data-table-td ">Controlling insects and acarina representatives; protecting plant propagation with fipronil and such as 2-chlorothiazol-5-ylmethyl-3-ethyl-4-nitroimino-perhydro-1,3,5-oxadiazine</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7728011">US7728011</a></td><td class="patent-data-table-td patent-date-value">Oct 9, 2003</td><td class="patent-data-table-td patent-date-value">Jun 1, 2010</td><td class="patent-data-table-td ">Bayer Animal Health Gmbh</td><td class="patent-data-table-td ">Dermally applicable liquid formulations for controlling parasitic insects on animals</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8178116">US8178116</a></td><td class="patent-data-table-td patent-date-value">Oct 24, 2003</td><td class="patent-data-table-td patent-date-value">May 15, 2012</td><td class="patent-data-table-td ">Piedmont Pharmaceuticals, Llc</td><td class="patent-data-table-td ">Topically administering to an area on the subject where ectoparasites are present a composition comprising a fatty acid ester and at least 20% cyclic siloxane</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8673813">US8673813</a></td><td class="patent-data-table-td patent-date-value">Mar 16, 2004</td><td class="patent-data-table-td patent-date-value">Mar 18, 2014</td><td class="patent-data-table-td ">Syngenta Crop Protection Llc</td><td class="patent-data-table-td ">Pesticide</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8728507">US8728507</a></td><td class="patent-data-table-td patent-date-value">Oct 31, 2007</td><td class="patent-data-table-td patent-date-value">May 20, 2014</td><td class="patent-data-table-td ">Bayer Intellectual Property Gmbh</td><td class="patent-data-table-td ">Non-systemic control of parasites</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0946099A1?cl=en">EP0946099A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by third party"> †</span></td><td class="patent-data-table-td patent-date-value">Dec 11, 1997</td><td class="patent-data-table-td patent-date-value">Oct 6, 1999</td><td class="patent-data-table-td ">Bayer Aktiengesellschaft</td><td class="patent-data-table-td ">Endoparasiticidal and ectoparasiticidal agents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1809106A2?cl=en">EP1809106A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 31, 2005</td><td class="patent-data-table-td patent-date-value">Jul 25, 2007</td><td class="patent-data-table-td ">Makhteshim Chemical Works Limited</td><td class="patent-data-table-td ">Pesticidal composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2015636A2?cl=en">EP2015636A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 27, 2007</td><td class="patent-data-table-td patent-date-value">Jan 21, 2009</td><td class="patent-data-table-td ">Summit Vetpharm, LLC</td><td class="patent-data-table-td ">High concentration topical insecticides containing pyrethroids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2258194A2?cl=en">EP2258194A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 31, 2005</td><td class="patent-data-table-td patent-date-value">Dec 8, 2010</td><td class="patent-data-table-td ">Makhteshim Chemical Works Limited</td><td class="patent-data-table-td ">Pesticidal composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2006048868A2?cl=en">WO2006048868A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 31, 2005</td><td class="patent-data-table-td patent-date-value">May 11, 2006</td><td class="patent-data-table-td ">Makhteshim Chem Works Ltd</td><td class="patent-data-table-td ">Pesticidal composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2007143298A2?cl=en">WO2007143298A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 27, 2007</td><td class="patent-data-table-td patent-date-value">Dec 13, 2007</td><td class="patent-data-table-td ">Summit Vetpharm Llc</td><td class="patent-data-table-td ">High concentration topical insecticides containing pyrethroids</td></tr></table><div class="patent-section-footer">* Cited by examiner, † Cited by third party</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=R6lNBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S341000">514/341</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=R6lNBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0043400000">A01N43/40</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=R6lNBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0043860000">A01N43/86</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=R6lNBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0051000000">A01N51/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=R6lNBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0043360000">A01N43/36</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=R6lNBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0061000000">A01N61/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=R6lNBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0043500000">A01N43/50</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=R6lNBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0043780000">A01N43/78</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=R6lNBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S514/83">Y10S514/83</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=R6lNBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A01N61/00">A01N61/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=R6lNBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A01N51/00">A01N51/00</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A01N51/00</span>, <span class="nested-value">A01N61/00</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Apr 1, 2013</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">BAYER INTELLECTUAL PROPERTY GMBH, GERMANY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAYER ANIMAL HEALTH GMBH;REEL/FRAME:030127/0549</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20120401</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jan 22, 2013</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CLAIM 1 IS DETERMINED TO BE PATENTABLE AS AMENDED.CLAIMS 2-3, DEPENDENT ON AN AMENDED CLAIM, ARE DETERMINED TO BE PATENTABLE.NEW CLAIMS 4-22 ARE ADDED AND DETERMINED TO BE PATENTABLE.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 6, 2011</td><td class="patent-data-table-td ">CC</td><td class="patent-data-table-td ">Certificate of correction</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Jun 28, 2011</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20110511</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 18, 2011</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">12</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 5, 2009</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">BAYER ANIMAL HEALTH GMBH, GERMANY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAYER AKTIENGESELLSCHAFT;REEL/FRAME:022203/0972</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20081204</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 25, 2007</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jun 16, 2003</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jun 2, 1997</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">BAYER AG, GERMANY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SIRINYAN, KIRKOR;DORN, HUBERT;KUJANEK, RICHARD;AND OTHERS;REEL/FRAME:008612/0823;SIGNING DATES FROM 19970325 TO 19970520</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U0W_9oCvsvLxoT8BJt6UVBbY1FBFQ\u0026id=R6lNBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U2XbjLG6T8tevkm8s2y-tSjsDGwQw\u0026id=R6lNBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U0ahMgwRaAtRV4_K-RKMJyVc1a3ag","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Parasiticide_formulations_suitable_for_d.pdf?id=R6lNBAABERAJ\u0026output=pdf\u0026sig=ACfU3U0-SH30hvW1mPep9wSG6OhJb4Kpbg"},"sample_url":"http://www.google.com/patents/reader?id=R6lNBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>